Hawaii's Kilauea Volcano erupts for the 25th time since December. Lava reaches over 330 feet
HILO, Hawaii (AP) — One of the world's most active volcanoes, Kilauea on Hawaii's Big Island, began spewing lava from the north vent Wednesday, the latest event in an ongoing eruption that began almost six months ago.
Lava fountains reached heights of more than 330 feet (100 meters) and feeding multiple lava streams. Scientists with the U.S. Geological Survey's Hawaiian Volcano Observatory said the fountains were likely to go higher.
The latest event was preceded by gas-pistoning, in which gas accumulates at a lava column's top within a vent, on Tuesday.
The observatory said this process causes the lava surface to rise or piston. 'Eventually, gas escapes as splatter/lava is erupted, and lave drains back into the vent,' the observatory wrote on its Facebook page.
These were occurring up to 10 times an hour, but increased in intensity until a small, sustained dome fountain began to feed flows to the crater floor a day later.
It is the 25th eruptive episode since the volcano on the southeastern part of the island began erupting Dec. 23. It has been pausing and resuming since.
Most of the eruptive episodes have spewed lava for about a day or less, with pauses between them generally lasting a few days.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
an hour ago
- Medscape
Nivolumab Plus Chemotherapy Improves Survival in Lung Cancer
Adding nivolumab to neoadjuvant chemotherapy significantly improved 5-year overall survival among patients with resectable non-small cell lung cancer (NSCLC), according to findings from a phase 3 trial presented at the recent American Society of Clinical Oncology (ASCO) 2025 annual meeting. The survival benefit was more pronounced in patients who achieved a pathologic complete response or a presurgery clearance of circulating tumor DNA (ctDNA). METHODOLOGY: The phase 3 CheckMate 816 trial has shown that compared with neoadjuvant chemotherapy alone, nivolumab plus chemotherapy improvespathologic complete response rates and event-free survival in patients with stage IB-IIIA resectable NSCLC. Based on these findings, this regimen was approved for this patient population in the US, EU, and other places. compared with neoadjuvant chemotherapy alone, nivolumab plus chemotherapy improvespathologic complete response rates and event-free survival in patients with stage IB-IIIA resectable NSCLC. Based on these findings, this regimen was approved for this patient population in the US, EU, and other places. Researchers are now reporting the final, prespecified analysis of overall survival. In the trial, 358 patients with stage IB-IIIA resectable NSCLC were randomly assigned to receive either nivolumab plus platinum-based chemotherapy or platinum-based chemotherapy alone every 3 weeks for three cycles. Surgery was performed within 6 weeks of completing neoadjuvant treatment. Postoperative adjuvant chemotherapy, radiotherapy, or both were permitted. Primary endpoints were event-free survival and pathologic complete response. Overall survival was the key secondary endpoint. The median follow-up duration was 68.4 months. TAKEAWAY: The 5-year overall survival rate was 65.4% with nivolumab plus chemotherapy vs 55.0% with chemotherapy alone. Nivolumab plus chemotherapy reduced the risk for death by 28% (hazard ratio [HR], 0.72; P = .048). = .048). Among patients who received the combination therapy, the 5-year overall survival rate was 95.3% for those who achieved a pathological complete response vs 55.7% for those who did not. Overall, 24% of patients in the nivolumab group achieved a pathological complete response vs only 2.2% in the chemotherapy group. ctDNA clearance before surgery was a strong prognostic indicator, regardless of treatment. At 5 years, overall survival was 75.0% among patients with ctDNA clearance vs 52.6% in those without (HR for death, 0.38 in the nivolumab group and 0.39 in the chemotherapy-only group). The combination therapy was associated with consistent survival benefits across disease stage and PDL-1 expression levels. The 5-year lung cancer-specific survival rate was 74.9% with nivolumab plus chemotherapy vs 65.1% with chemotherapy alone (HR, 0.65). No new safety concerns emerged, and there were no new deaths related to a trial treatment. IN PRACTICE: 'In this trial, we found that the use of neoadjuvant nivolumab plus chemotherapy resulted in significantly longer overall survival than chemotherapy alone, along with long-term benefit regarding event-free survival,' the authors wrote. 'These findings support the hypothesis that neoadjuvant chemoimmunotherapy can have a profound impact on the course of a patient's life when paired with the curative potential of surgical resection.' SOURCE: This study, led by Patrick M. Forde, MB, BCh, PhD, Trinity St. James's Cancer Institute, Trinity College Dublin, Dublin, Ireland, was published online in The New England Journal of Medicine and presented at ASCO. LIMITATIONS: Although the overall survival with nivolumab plus chemotherapy achieved statistical significance, the margin was narrow. Additionally, several subgroups in the exploratory analyses were too small for adequate statistical comparison, requiring cautious interpretation of these results. Black patients were underrepresented, which may have affected the generalizability of the findings. DISCLOSURES: This study was funded by Bristol Myers Squibb. Five authors declared being employees of Bristol Myers Squibb, with some holding stock or stock options with the company. Several authors declared working as consultants or having other ties with various sources including Bristol Myers Squibb.
Geek Girl Authority
an hour ago
- Geek Girl Authority
SPACEBALLS Sequel and Key Cast Members Announced
Mel Brooks has shared that Spaceballs 2 is on the horizon. Spaceballs 2 The announcement comes in the form of a brief trailer, which you can watch below. In addition to Brooks reprising his role, Rick Moranis and Bill Pullman are also returning. The legendary Mel Brooks has announced that one of the most beloved comedy movies of all time is getting a sequel. Spaceballs 2 is on its way and is scheduled to arrive in 2027. Here's what we know so far about the immediately highly anticipated sequel, coming from Amazon MGM+ Studios. Spaceballs 2: The Search for More Money Obviously, with the movie two years away, we only know so much about it at the moment. However, one extremely exciting element we are aware of is several returning cast members. These will include Rick Moranis as Dark Helmet. This casting inclusion is especially exciting because Moranis has so rarely appeared onscreen since taking a sabbatical from acting in 1997. RELATED: Star Trek: Lower Decks : 7 Non-Franchise References But the exciting casting doesn't stop there. Also returning will be Bill Pullman as Lone Starr. And Brooks, who will be 100 years old when the movie debuts, will reprise the role of Yogurt. Joining the cast will be some fresh faces, too, including Keke Palmer. Spaceballs 2 will be written by Benji Samit, Dan Hernandez and Josh Gad. It will be directed by Josh Greenbaum, whose previous work includes the hilarious buddy comedy Barb and Star Go to Vista Del Mar. The original Spaceballs was released in 1987. The comedy is a send-up of Star Wars that also parodies other popular sci-fi franchises. Including, memorably, a singing and dancing version of Alien 's chestburster. It's worth mentioning that, during the original movie, the aforementioned Yogurt did suggest a sequel. His proposed title for the movie was Spaceballs 2: The Search for More Money . RELATED: 8 Star Trek References in the Futurama DVD Movies Spaceballs 2 was announced via a trailer, which you can watch for yourself below. Before an introduction from Brooks, the Spaceballs theme plays. It's accompanied by a blue text crawl that parodies the opening of Star Wars movies. And it points out that many, many genre franchise movies (and shows) have been released since the first Spaceball s . Source: Deadline. The original Spaceballs is currently available for streaming on HBO Max. STAR TREK: STRANGE NEW WORLDS: Paramount Announces Fifth and Final Season Avery Kaplan is the author of several books and the Features Editor at Comics Beat. She was honored to serve as a judge for the 2021 Cartoonist Studio Prize Award and the 2021 Prism Awards. She lives in the mountains of Southern California with her partner and a pile of cats, and her favorite place to visit is the cemetery. You can also find her writing on Comics Bookcase, NeoText, Shelfdust, the Mary Sue, in many issues of PanelxPanel, and in the margins of the books in her personal library.
Yahoo
3 hours ago
- Yahoo
Gov. Shapiro delivers commencement address at West Scranton High School
Jun. 12—SCRANTON — Gov. Josh Shapiro on Wednesday told the West Scranton High School Class of 2025 graduating class that there are many different paths that their journey can take them down. "And hear me on this — there's no wrong path," Shapiro said. "There's only your path. There are many avenues to success. And we've got to respect — and support — all of them." Shapiro spoke directly to the 338 West Scranton High School graduates, their parents and teachers and staff, reminding the graduates that they represent the opportunity to chart their own course and succeed in Pennsylvania. The ceremony was held at the Lackawanna College Student Union building in Scranton. Since day one, Shapiro said he has worked to open doors of opportunity for all Pennsylvanians, no matter their path. On his first day in office, the governor said he signed an executive order announcing that 92% of state government jobs are open to Pennsylvanians without a college degree — and since then, nearly 60% of the Commonwealth's new hires do not have a four-year degree. Shapiro said he also made historic investments in public education — creating real opportunity for students, supporting teachers and school staff and delivering results across the Commonwealth. The governor said he has secured more than $2 billion in additional funding for K-12 public education — the largest investment in Pennsylvania history. And just two days earlier, the governor was in Berwick to announce that Amazon is planning to invest at least $20 billion to establish multiple high-tech cloud computing and artificial intelligence innovation campuses across the Commonwealth of Pennsylvania. He said this initial investment from Amazon will create thousands of good-paying, stable jobs as Pennsylvania workers build, maintain, and operate the first two data center campuses — one in Luzerne County and another in Bucks County. Shapiro said this marks the largest private sector investment in the history of Pennsylvania. In his address, Shapiro said the students are key to Pennsylvania's future. "We have literally invested in your success," Shapiro said. "That is money very well spent. And you more than held up your end of the deal — you studied hard, tried new things, and accomplished a ton. And now, you're about to set out on your journey through life, stronger because of your West Scranton education." Shapiro said his administration has increased funding for vo-tech, career and technical education and apprenticeships, while investing in making college more affordable. "Consider this — right here at West, nearly 60 students from your graduating class completed classes at the Scranton-Lackawanna CTC," Shapiro said. "They studied everything from automotive and culinary arts to nursing and robotics. And 22% of your classmates here today — nearly 80 students — are going to take the skills they learned and go straight into the workforce. Another 10% are going to trade school; 8 of you are going into the military to serve our nation; and about half of you are going to college." Shapiro told the graduates that they are a great representation of the diversity of opportunities available here in Pennsylvania. "Each of you — no matter what path you choose — has the opportunity to be successful," he said. "And so if you remember only one thing from our time here today — remember that your governor showed up at your graduation because he gives a damn about you and asked you to blaze your own path. Chart your own course and follow your own gut. Live your own failures and find your own success." The Governor shares his story "When I graduated high school, my dream was to go to college, play on the basketball team, study pre-med, and then become a doctor — or maybe even be good enough to play professional basketball," Shapiro said. "You see how that turned out. I am none of those things. Instead, I flunked out of pre-med and got cut from the basketball team — on the very same day. "But I didn't give up. Instead, I found a passion for service that's guided my life's work ever since." Reach Bill O'Boyle at 570-991-6118 or on Twitter @TLBillOBoyle.
